Retro Biosciences aims to extend healthy human lifespan through programs in autophagy, cell replacement and tissue reprogramming. Its lead oral drug, RTR242,…
AI + MedicineIn breast screening, AI support has been tested in a randomized trial of more than 100,000 women and a real-world study of 460,000. The results are promising, but false alarms, overdiagnosis and deskilling still matter.
AI + MedicinePersonalized computer models of the heart and in-silico trials are already used in research and regulation. Scaling them into a living digital twin for every patient raises hard questions of biology, validation and trust.